Boston, MA · Founded 2018 · Privately Held (backing)
Provider of clinical research and development services intended to treat systemic and life-threatening fungal infections. Elion Therapeutics is based in Boston, MA and was founded in 2018. Its last reported valuation was $163 million in Aug 2025. It has raised $111 million.
Last reported valuation
$163.0M
Oct 2026
Priced at
—
Total raised
$111.0M
Last round
—
Team — not yet on record
No current team members for Elion Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Elion Therapeutics with a free account
·Watch Elion Therapeutics: the Monday email on marks, rounds and moves
